- |||||||||| AMG 171 / Amgen
Trial completion date, Trial termination, Trial primary completion date: Single and Multiple Ascending Dose Study of AMG 171 in Subjects With Obesity (clinicaltrials.gov) - Jan 10, 2022
P1, N=60, Terminated,
Trial completion date: Apr 2022 --> Sep 2021 | Recruiting --> Terminated | Trial primary completion date: Apr 2022 --> Sep 2021; Amgen determined the totality of the data does not support continuation of AMG 171 development program for treatment of Obesity. No safety concerns identified.
- |||||||||| AMG 171 / Amgen
Enrollment change, Trial completion date, Trial primary completion date: Single and Multiple Ascending Dose Study of AMG 171 in Subjects With Obesity (clinicaltrials.gov) - Dec 31, 2020
P1, N=48, Recruiting,
Trial completion date: Aug 2021 --> Apr 2022 | Trial primary completion date: Aug 2021 --> Apr 2022 N=148 --> 48 | Trial completion date: Mar 2022 --> Aug 2021 | Trial primary completion date: Mar 2022 --> Aug 2021
- |||||||||| AMG 171 / Amgen
Trial completion date, Trial primary completion date: Single and Multiple Ascending Dose Study of AMG 171 in Subjects With Obesity (clinicaltrials.gov) - Apr 2, 2020
P1, N=148, Recruiting,
N=148 --> 48 | Trial completion date: Mar 2022 --> Aug 2021 | Trial primary completion date: Mar 2022 --> Aug 2021 Trial completion date: Sep 2022 --> Dec 2021 | Trial primary completion date: Sep 2022 --> Dec 2021
|
